BDBM281767 2-(3-(1H-pyrrolo[2,3-b]pyridin- 3-yl)benzylamino)-N-(4- fluorobenzyl)nicotinamide::US10030016, Example 1.6
SMILES: Fc1ccc(CNC(=O)c2cccnc2NCc2cccc(c2)-c2c[nH]c3ncccc23)cc1
InChI Key: InChIKey=LZRXHNBORXWYRR-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3-phosphoinositide-dependent protein kinase 1 [51-359] (Homo sapiens (Human)) | BDBM281767 (2-(3-(1H-pyrrolo[2,3-b]pyridin- 3-yl)benzylamino)-...) | PDB GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Sunesis Pharmaceuticals, Inc.; Millenium Pharmaceuticals, Inc. US Patent | Assay Description PDK1 (amino acids 51-359) and AKT2 (amino acids 140-467 fused to PIFtide, amino acids EEQEMFRDFDYIADW) were expressed as N-terminally tagged GST fusi... | US Patent US10030016 (2018) BindingDB Entry DOI: 10.7270/Q2S46V16 | |||||||||||
More data for this Ligand-Target Pair |